Literature DB >> 26565033

The SUMO (Small Ubiquitin-like Modifier) Ligase PIAS3 Primes ATR for Checkpoint Activation.

Ching-Shyi Wu1, Lee Zou2.   

Abstract

The maintenance of genomic stability relies on the concerted action of DNA repair and DNA damage signaling pathways. The PIAS (protein inhibitor of activated STAT) family of SUMO (small ubiquitin-like modifier) ligases has been implicated in DNA repair, but whether it plays a role in DNA damage signaling is still unclear. Here, we show that the PIAS3 SUMO ligase is important for activation of the ATR (ataxia telangiectasia and Rad3 related)-regulated DNA damage signaling pathway. PIAS3 is the only member of the PIAS family that is indispensable for ATR activation. In response to different types of DNA damage and replication stress, PIAS3 plays multiple roles in ATR activation. In cells treated with camptothecin (CPT), PIAS3 contributes to formation of DNA double-stranded breaks. In UV (ultraviolet light)- or HU (hydroxyurea)-treated cells, PIAS3 is required for efficient ATR autophosphorylation, one of the earliest events during ATR activation. Although PIAS3 is dispensable for ATRIP (ATR-interacting protein) SUMOylation and the ATR-ATRIP interaction, it is required for maintaining the basal kinase activity of ATR prior to DNA damage. In the absence of PIAS3, ATR fails to display normal kinase activity after DNA damage, which accompanies with reduced phosphorylation of ATR substrates. Together, these results suggest that PIAS3 primes ATR for checkpoint activation by sustaining its basal kinase activity, revealing a new function of the PIAS family in DNA damage signaling.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  DNA damage response; DNA repair; DNA replication; checkpoint control; small ubiquitin-like modifier (SUMO)

Mesh:

Substances:

Year:  2015        PMID: 26565033      PMCID: PMC4697162          DOI: 10.1074/jbc.M115.691170

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Topoisomerase I poisoning results in PARP-mediated replication fork reversal.

Authors:  Arnab Ray Chaudhuri; Yoshitami Hashimoto; Raquel Herrador; Kai J Neelsen; Daniele Fachinetti; Rodrigo Bermejo; Andrea Cocito; Vincenzo Costanzo; Massimo Lopes
Journal:  Nat Struct Mol Biol       Date:  2012-03-04       Impact factor: 15.369

2.  Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein.

Authors:  Joost Schimmel; Karolin Eifler; Jón Otti Sigurðsson; Sabine A G Cuijpers; Ivo A Hendriks; Matty Verlaan-de Vries; Christian D Kelstrup; Chiara Francavilla; René H Medema; Jesper V Olsen; Alfred C O Vertegaal
Journal:  Mol Cell       Date:  2014-02-27       Impact factor: 17.970

3.  Nek1 kinase associates with ATR-ATRIP and primes ATR for efficient DNA damage signaling.

Authors:  Shizhou Liu; Chu Kwen Ho; Jian Ouyang; Lee Zou
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

4.  The E3 ligase Topors induces the accumulation of polysumoylated forms of DNA topoisomerase I in vitro and in vivo.

Authors:  Eva Hammer; Regine Heilbronn; Stefan Weger
Journal:  FEBS Lett       Date:  2007-10-30       Impact factor: 4.124

5.  RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair.

Authors:  Yaron Galanty; Rimma Belotserkovskaya; Julia Coates; Stephen P Jackson
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

6.  SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage.

Authors:  Yili Yin; Anne Seifert; Joy Shijia Chua; Jean-François Maure; Filip Golebiowski; Ronald T Hay
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

7.  Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I-DNA complexes.

Authors:  Marie Regairaz; Yong-Wei Zhang; Haiqing Fu; Keli K Agama; Nalini Tata; Surbhi Agrawal; Mirit I Aladjem; Yves Pommier
Journal:  J Cell Biol       Date:  2011-11-28       Impact factor: 10.539

8.  Expression of STAT5, COX-2 and PIAS3 in correlation with NSCLC histhopathological features.

Authors:  Dorota Pastuszak-Lewandoska; Daria Domańska; Karolina H Czarnecka; Jacek Kordiak; Monika Migdalska-Sęk; Ewa Nawrot; Justyna Kiszałkiewicz; Adam Antczak; Paweł Górski; Ewa Brzeziańska
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

9.  Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks.

Authors:  Yaron Galanty; Rimma Belotserkovskaya; Julia Coates; Sophie Polo; Kyle M Miller; Stephen P Jackson
Journal:  Nature       Date:  2009-12-17       Impact factor: 49.962

10.  PIAS3 expression in squamous cell lung cancer is low and predicts overall survival.

Authors:  Rime Abbas; Karen S McColl; Adam Kresak; Michael Yang; Yanwen Chen; Pingfu Fu; Gary Wildey; Afshin Dowlati
Journal:  Cancer Med       Date:  2015-01-09       Impact factor: 4.711

View more
  10 in total

Review 1.  SUMO-Mediated Regulation of Nuclear Functions and Signaling Processes.

Authors:  Xiaolan Zhao
Journal:  Mol Cell       Date:  2018-08-02       Impact factor: 17.970

Review 2.  Cooperativity of the SUMO and Ubiquitin Pathways in Genome Stability.

Authors:  Minghua Nie; Michael N Boddy
Journal:  Biomolecules       Date:  2016-02-25

3.  Pias3 is necessary for dorso-ventral patterning and visual response of retinal cones but is not required for rod photoreceptor differentiation.

Authors:  Christie K Campla; Hannah Breit; Lijin Dong; Jessica D Gumerson; Jerome E Roger; Anand Swaroop
Journal:  Biol Open       Date:  2017-06-15       Impact factor: 2.422

4.  Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition.

Authors:  Jiantong Jiao; Rui Zhang; Zheng Li; Ying Yin; Xiangming Fang; Xiaopeng Ding; Ying Cai; Shudong Yang; Huijun Mu; Da Zong; Yuexin Chen; Yansong Zhang; Jian Zou; Junfei Shao; Zhaohui Huang
Journal:  Nat Commun       Date:  2018-06-27       Impact factor: 14.919

5.  PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation.

Authors:  Bo Xie; Xinyu Liu; Jie Yang; Jinke Cheng; Jianmin Gu; Song Xue
Journal:  BMC Cell Biol       Date:  2018-11-12       Impact factor: 4.241

6.  The S phase checkpoint promotes the Smc5/6 complex dependent SUMOylation of Pol2, the catalytic subunit of DNA polymerase ε.

Authors:  Alicja Winczura; Rowin Appanah; Michael H Tatham; Ronald T Hay; Giacomo De Piccoli
Journal:  PLoS Genet       Date:  2019-11-25       Impact factor: 5.917

7.  Site-specific SUMOylation of viral polymerase processivity factor: a way of localizingtoND10 subnuclear domains for restricted and self-controlled reproduction of herpesvirus.

Authors:  Shuyan Lai; Mengqiong Xu; Yaohao Wang; Ruilin Li; Chuan Xia; Sisi Xia; Jun Chen
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 8.  ATR-mediated regulation of nuclear and cellular plasticity.

Authors:  Gururaj Rao Kidiyoor; Amit Kumar; Marco Foiani
Journal:  DNA Repair (Amst)       Date:  2016-05-16

9.  Mitotic and Meiotic Functions for the SUMOylation Pathway in the Caenorhabditis elegans Germline.

Authors:  Rachel Reichman; Zhuoyue Shi; Robert Malone; Sarit Smolikove
Journal:  Genetics       Date:  2018-02-22       Impact factor: 4.562

Review 10.  Insights in Post-Translational Modifications: Ubiquitin and SUMO.

Authors:  Daniel Salas-Lloret; Román González-Prieto
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.